top of page
Screen Shot 2023-02-19 at 1.26.38 PM.png


The amino acid sequence of human IL-7


An optimized glycosylation profile in a biologic buffer


Drug product designed to maximize hydrophilicity

CYT107 administration frequency once or twice a week to privilege a safe approach


Perfectly fitting the turn over of the IL-7 receptor availability


Treatment can be stopped or restarted at anytime

bottom of page